Business
Else Nutrition targets FDA approval as it eyes news markets for its plant-based infant nutrition
(NewsDirect) Else Nutrition CEO Hamutal Cohen Yitzhak tells Proactive's Stephen Gunnion t...
About this update from Else Nutrition Holdings Inc
[{"type":"text","content":"Else Nutrition targets FDA approval as it eyes news markets for its plant-based infant nutrition\n \n \n (NewsDirect)\n \n \n \n \n Else Nutrition CEO Hamutal Cohen Yitzhak\ntells Proactive's Stephen Gunnion that a number of catalyst lie\nahead for the company this year, including the launch of its\n'ready-to-drink' infant nutrition in the US, its entry to the\nUK market as a starting point for Europe and Australia as a gateway to\nChina.\n \n \n Importantly, she said the company remains on track to\nbegin its infant growth clinical study for the FDA and European\npermits. Receiving FDA approval is a very high priority for Else\nNutrition, as it believes that becoming the first non-dairy and\nnon-soy FDA-approved infant formula will be transformational. Yitzhak\nalso commented on Else's first-quarter results, which showed an\n80% year-over-year increase in revenue to $2.9\nmillion.\n \n \n \n Contact Details\n \n \n \n \n Proactive United\nStates\n \n \n \n Proactive United States\n \n \n +1\n347-449-0879\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":1462,"tagName":"div"}]